Indoco Remedies Ltd.

INDOCO

₹238.86

-0.71% (-1.71)

Market Cap

₹2,223 Cr.

P/E

0.00

About

Indoco Remedies Limited is a Public Limited Company domiciled in India and incorporated under the provision of the Companies Act, VII of 1913. Indoco Remedies Limited is engaged in the manufacturing a… Read more

Indoco Remedies Limited is a Public Limited Company domiciled in India and incorporated under … Read more

Low

190

52W Range

High

388

Timeline

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statementNew

Edit rows

Forensics

11 Yes

Positive for this company

0 Neutral

Neutral for this company

6 No

Negative for this company

0 No Data

Insufficient data to analyse

Accounting & Shareholding

Contingent Liabilities

Company does not have significant contingent liabilities
Depreciation Effect

Depreciation accounting is not leading to increase in profits
Other Income

Other income is not affecting ratios of the company
Pledge

Promoters have not pledged a significant portion of their holding
Promoter Holding

Promoter has been buying shares from the open market over last 90 days
Retail Holding

Retail has been selling the stock which is usually a good time to buy
Revenue Recognition

Chances of aggressive revenue recognition - operating profit of company is not getting converted to cash and recievables rising faster than sales

Price & Performance

ROE

Asset turnover is responsible for roe increase over last 10 years
Share price

Share price has increased over last 10 years due to earnings
Working Capital

Working capital of the company seems to be under control
Debt

Company should not have issues servicing its debt
Balance Sheet Strength

Balance sheet of the company is strong. it shouldnt have solvency or liquidity issues
Capex vs ROCE

Roce of the company has decreased even without significant capex
Current vs Historic Valuation

Company is trading at a premium to 3yr historic valuations
Sales Growth

Sales of the company has grown at a slow pace
Margin Stability

Margins of the company are volatile
ROCE Strength

Roce of the company is not consistently strong

Market Share

0.24 %

(as of Jul 22)

Historic

Anti - Diabetes - Market Share

0.99 %

(as of Jul 22)

Historic

Anti-Infectives - Market Share

0.60 %

(as of Nov 21)

Historic

Blood Related - Market Share

0.02 %

(as of Jul 22)

Historic

Cardiovascular - Market Share

5.50 %

(as of Mar 23)

Source/Historic

Carmicide - Market Share

49.90 %

(as of Mar 23)

Source/Historic

Cyclopam - Market Share

0.36 %

(as of Nov 21)

Historic

Dermatology - Market Share

0.82 %

(as of Jul 22)

Historic

Gastro-Intestinal - Market Share

0.24 %

(as of Nov 21)

Historic

Gynecology - Market Share

88.70 %

(as of Mar 23)

Source/Historic

Homide - Market Share

65.60 %

(as of Mar 23)

Source/Historic

Karvol Plus - Market Share

63.20 %

(as of Mar 23)

Source/Historic

Kidodent - Market Share

2.12 %

(as of Nov 21)

Historic

Ophthalmology - Market Share

0.30 %

(as of Nov 21)

Historic

Pain - Market Share

0.60 %

(as of Dec 22)

Historic

Pharmaceutical Sector - Market Share

52.20 %

(as of Mar 23)

Source/Historic

Renolen - Market Share

1.50 %

(as of Nov 21)

Historic

Respiratory - Market Share

80 %

(as of Mar 23)

Source/Historic

Rexidin M - Market Share

55.50 %

(as of Mar 21)

Source/Historic

Rexidin Plus - Market Share

97.70 %

(as of Mar 23)

Source/Historic

Sensodent-K - Market Share

47.80 %

(as of Mar 23)

Source/Historic

Sensodent-KF - Market Share

60.30 %

(as of Mar 23)

Source/Historic

Sensoform - Market Share

100 %

(as of Mar 23)

Source/Historic

Snowdent - Market Share

23.05 %

(as of Nov 21)

Historic

Stomatological - Market Share

2.45 %

(as of Nov 21)

Historic

Urology - Market Share

0.58 %

(as of Jul 22)

Historic

Vitamin & Dietary Supplements - Market Share

Revenue mix

Product Wise Break-Up

Therapeutic Area Wise Break-Up - Domestic

Location Wise Break-Up - Formulation

Location Wise Break-Up

Operational Metrics

US DMF Filings (.)
Source
Global DMFs filed (.)
Number of ANDA's Filed in USA (.)
Source
Number of ANDA's Approved By USFDA (.)
Source
Domestic Sales Growth - YoY (%)
Source
R&D as a % of Total Sales (%)
Source

Peer Comparison

Corporate Actions

Consolidated

DATE

DETAILS

Show Less

Suppliers

Aarti Drugs Ltd.
IOL Chemicals And Pharmaceuticals Ltd.
Kilitch Drugs (India) Ltd.

FAQs on Indoco Remedies Ltd. Business

What does Indoco Remedies do?

Indoco Remedies Limited, based in India, specializes in manufacturing and marketing Formulations and Active Pharmaceutical Ingredients for domestic and international markets.

Who are the competitors of Indoco Remedies?

Indoco Remedies major competitors are Novartis, Zota Health Care, Beta Drugs, Syncom Formulations, Jagsonpal Pharma, Panacea Biotec, Bliss GVS Pharma.
Market Cap of Indoco Remedies is ₹2,223 Crs.
While the median market cap of its peers are ₹1,875 Crs.

Is Indoco Remedies financially stable compared to its competitors?

Indoco Remedies seems to be less financially stable compared to its competitors.
Altman Z score of Indoco Remedies is 3.16 and is ranked 7 out of its 8 competitors.

View FAQ's On Shareprice

Cash Flow Machines

Actual Cash profits are more important than accounting profits. List of companies spitting out cash profits

Run Query

Global Leaders

Companies with a dominant global position in a product. Might be a sign of very strong moat.

Run Query

Reasonably Valued Domestic Healthcare Companies

Healthcare companies trading at a decent valuation

Run Query

Company Filing

	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Annual Report	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Earnings Release		Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Jun Sep Dec	Feb Jun Sep Dec	Dec		Mar Jun Sep Dec	Mar Jun	Jun Sep Dec	Mar Jun Sep Dec
Investor Presentation		Mar Sep							Mar		Jun	Mar	Dec	Mar
Conference Call		Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Jun Sep Dec
Conference Call SummaryCon Call Summary Powered by Gemini

Discussions & Analysis

Indoco Remedies Ltd.

One Hidden Stock in the Pharma Sector! Growing Really Fast - SOIC

Why Indoco Remedies looks Interesting and why FY22-24 growth is likely to be stellar here? - SOIC

View the discussion on ValuePickr

Business Analysis - A thread on Indoco Remedies - Value Educator

Detailed Analysis on the business of Indoco Remedies - Value Educator

Pharmaceutical Sector

How The Pharma Industry Works - PPFAS

Deep Dive into Pharma Sector - Omkara Capital

Pharma Compliance In-Depth - Amit Rajan

Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar

Nutraceuticals- Industry Overview - Value Educator

Generic Opportunity for Indian Pharma Companies - Anish Moonka

Understanding the CDMO Sector - Will It Be The Next Megatrend - SOIC

Ideas Dashboard

Timeline

Watchlist

Portfolio

Alerts

Research

Stock Screener

Market

Raw Material

Indoco Remedies Ltd.